THE DISCOVERY AND DEVELOPMENT OF BUSPIRONE - A NEW APPROACH TO THE TREATMENT OF ANXIETY

被引:72
作者
NEW, JS
机构
[1] Preclinical CNS Research, Pharmaceutical Research and Development Division, Bristol-Myers Squibb Co., Wallingford, Connecticut
关键词
D O I
10.1002/med.2610100302
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
[No abstract available]
引用
收藏
页码:283 / 326
页数:44
相关论文
共 173 条
[41]   INHIBITION OF FORSKOLIN-STIMULATED ADENYLATE-CYCLASE ACTIVITY BY 5-HT RECEPTOR AGONISTS [J].
DEVIVO, M ;
MAAYANI, S .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 119 (03) :231-234
[42]  
DOMPERT W, 1984, Patent No. 3321969
[43]   THE 5-HT1A AGONIST 8-OH-DPAT INCREASES CONSUMPTION OF PALATABLE WET MASH AND LIQUID DIETS IN THE RAT [J].
DOURISH, CT ;
COOPER, SJ ;
GILBERT, F ;
COUGHLAN, J ;
IVERSEN, SD .
PSYCHOPHARMACOLOGY, 1988, 94 (01) :58-63
[44]   PUTATIVE ANXIOLYTICS 8-OH-DPAT, BUSPIRONE AND TVX-Q-7821 ARE AGONISTS AT 5-HT1A AUTORECEPTORS IN THE RAPHE NUCLEI [J].
DOURISH, CT ;
HUTSON, PH ;
CURZON, G .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1986, 7 (06) :212-214
[45]   8-OH-DPAT-INDUCED HYPERPHAGIA - ITS NEURAL BASIS AND POSSIBLE THERAPEUTIC RELEVANCE [J].
DOURISH, CT ;
HUTSON, PH ;
KENNETT, GA ;
CURZON, G .
APPETITE, 1986, 7 :127-140
[46]  
DUMUIS A, 1988, MOL PHARMACOL, V33, P178
[47]   SEROTONERGIC MECHANISMS IN THE BEHAVIORAL-EFFECTS OF BUSPIRONE AND GEPIRONE [J].
EISON, AS ;
EISON, MS ;
STANLEY, M ;
RIBLET, LA .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1986, 24 (03) :701-707
[48]   REDUCTION IN CORTICAL 5HT2 RECEPTOR SENSITIVITY AFTER CONTINUOUS GEPIRONE TREATMENT [J].
EISON, AS ;
YOCCA, FD .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 111 (03) :389-392
[49]  
EISON M S, 1984, Society for Neuroscience Abstracts, V10, P259
[50]   ANTICONFLICT EFFECT OF THE PUTATIVE SEROTONIN RECEPTOR AGONIST 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN (8-OH-DPAT) [J].
ENGEL, JA ;
HJORTH, S ;
SVENSSON, K ;
CARLSSON, A ;
LILJEQUIST, S .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 105 (3-4) :365-368